Clinical Trials Browser

Phase 2 × Hodgkin Disease × apolizumab × Clear all

NCT00055783 2013-05-15

Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma